arrow
M

Marcos Malumbres

spanish national cancer research centre
H指数:74
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

miR-203 facilitates timely cell fate transitions via epigenetic modulation during early embryogenesis

miR-203通过表观遗传调控促进早期胚胎发育过程中的适时细胞命运转变。

2026-03-110
OA
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
2024-07-112
OAAI
PLK1 inhibition dampens NLRP3 inflammasome-elicited response in inflammatory disease models

PLK1抑制抑制炎症性疾病模型中NLRP3炎性体引起的反应

2023-11-012
OAAI
First results of the SOLTI-1903 HOPE's patient-centric molecular screening program in advanced breast cancer

SOLTI-1903希望以患者为中心的晚期乳腺癌分子筛查计划的第一个结果

2023-10-010
OAAI
miR-203 drives breast cancer cell differentiation

miR-203驱动乳腺癌细胞分化

2023-08-044
OAAI
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer

HOPE (SOLTI-1903) 乳腺癌研究: 以患者为中心的真实世界临床实践研究,评估基因组数据对局部晚期或转移性乳腺癌患者下一步治疗决策选择的影响

2023-04-281
OAAI
Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer

利用转录驱动的染色体不稳定性适应靶向治疗难治性致死性前列腺癌

2023-02-0113
OAAI
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A
2022-12-0711
OAAI
The MASTL/PP2A cell cycle kinase-phosphatase module restrains PI3K-Akt activity in an mTORC1-dependent manner

MASTL/PP2A细胞周期激酶-磷酸酶模块以mTORC1-dependent方式抑制PI3K-Akt活性

2022-11-107
OA